Explore comprehensive CDMO services offered by Dendreon Pharmaceuticals LLC, supporting end-to-end Anlaytical Testing, Drug Development and Manufacturing. Dendreon Pharmaceuticals LLC enables faster, compliant, and scalable pharma innovation tailored to your needs.
Country: U.S.A.
Description: Dendreon Pharmaceuticals LLC is a biopharmaceutical company specializing in cellular immunotherapy, particularly known for developing the first FDA-approved immunotherapy for prostate cancer, PROVENGE® (sipuleucel-T). It manufactures and provides end-to-end services for the cellular therapy market, focusing on oncology and developing novel therapeutics to treat cancer. Headquartered in Seal Beach, California, the company also develops other cancer treatments and supports its partners in bringing innovative cell therapies to market.
